Stock BRAINSTORM CELL THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Brainstorm Cell Therapeutics Inc OTC Bulletin Board

Equities

US10501E1029

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Brainstorm Cell Therapeutics Inc
04-17 Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 CI
04-17 Brainstorm Cell Therapeutics Inc. Announces Management Changes CI

Chart calendar Brainstorm Cell Therapeutics Inc

c42a.AytqFAe8slffIe6clkYbnOyUe8qwUB4jvE2te8BeOhE.bBkuRmiM-BmJVrzm7HdT0MHgGLroYytohSGVFJJma0h1XRh1Qe_-JKZ4iQ~82873aaa1a52727908767f0e8d5fca59

Upcoming events on Brainstorm Cell Therapeutics Inc

11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Brainstorm Cell Therapeutics Inc

Today Q1 2024 Earnings Release (Projected)
09/04/2024 13:00 Business Update Call
01/04/2024 13:05 Q4 2023 Earnings Release
05/03/2024 European Life Sciences CEO Forum
04/03/2024 23:00 MDA Clinical and Scientific Conference
28/02/2024 16:20 European Life Sciences CEO Forum
28/02/2024 12:40 European Life Sciences CEO Forum
17/12/2023 Annual General Meeting
14/11/2023 13:30 Q3 2023 Earnings Call
14/11/2023 12:05 Q3 2023 Earnings Release
18/10/2023 13:30 Business Update Call
26/09/2023 ADCOM Conference
14/08/2023 13:00 Q2 2023 Earnings Call
14/08/2023 12:05 Q2 2023 Earnings Release
05/07/2023 17:00 Gordon Research Conference
21/06/2023 14:00 Maxim Group Virtual Healthcare Conference
15/05/2023 13:00 Q1 2023 Earnings Call
15/05/2023 12:05 Q1 2023 Earnings Release
30/03/2023 13:00 Q4 2022 Earnings Call
30/03/2023 12:05 Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-23,0
-20,4
-13%		-31,7
-26,3
-20.41%		-24,5
-29,0
15.32%		-24,8
-25,9
4.18%		-21,4
-25,3
15.2%
-21,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-23,3
-20,5
-13.33%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-25,2
31.71%
-21,9

Net income
Million USD		Released
Forecast
Spread 		-23,3
-20,2
-15.39%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-23,0
25.37%
-21,9

EPS
USD		Released
Forecast
Spread 		-1,06
-0,91
-17.13%		-1,07
-0,89
-20.22%		-0,68
-0,79
13.92%		-0,66
-0,68
2.22%		-0,40
-0,56
28.57%
-0,28

Announcement Date18/02/2004/02/2128/03/2230/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,21
-7,17
13.3%		-5,48
-4,70
-16.49%		-7,59
-5,46
-39.14%		-6,84
-6,75
-1.39%		-4,92
-6,00
18.08%		-5,15
-6,01
14.24%		-5,45
-5,70
4.43%		-6,04
-6,00
-0.56%		-4,80
-6,33
24.1%
-4,50


-5,20


-5,80


-6,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,19
-7,17
13.61%		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%
-4,50


-5,20


-5,80


-6,40

Net income
Million USD		Released
Forecast
Spread 		-6,19
-7,17
13.61%		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%
-4,50


-5,20


-5,80


-6,40

EPS
USD		Released
Forecast
Spread 		-0,17
-0,20
12.82%		-0,15
-0,13
-15.38%		-0,19
-0,15
-31.03%		-0,19
-0,18
-5.56%		-0,13
-0,15
10.34%		-0,14
-0,17
15.15%		-0,13
-0,15
10.34%		-0,03
-0,15
79.31%		-0,11
-0,13
15.38%
-0,07


-0,07


-0,06


-0,07

Announcement Date28/03/2216/05/2215/08/2214/11/2230/03/2315/05/2314/08/2314/11/2301/04/24----

Upcoming sector events for Brainstorm Cell Therapeutics Inc

12/05/2024 DISC MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
12/05/2024 AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release (Projected)
12/05/2024 BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 BELITE BIO, INC: Q1 2024 Earnings Release
13/05/2024 ABSCI CORPORATION: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
15/05/2024 REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Brainstorm Cell Therapeutics Inc

Today BIOHAVEN LTD.: Q1 2024 Earnings Release (Projected)
Today HUMACYTE, INC.: Q1 2024 Earnings Release
Today NOVAVAX, INC.: Q1 2024 Earnings Release
Today TAKARA BIO INC.: Q4 2023 Earnings Release
Today CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected)
09/05/2024 12:30 INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 12:00 IRONWOOD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
09/05/2024 12:00 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q1 2024 Earnings Release
08/05/2024 POLARIS GROUP: Q1 2024 Earnings Release (Projected)
08/05/2024 VORONOI, INC.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. Stock
  5. Calendar Brainstorm Cell Therapeutics Inc